Company intelligence / Profile preview

Emblok

Tampa, Florida, United States

Ownership: Private
Development stage: Other

Overview

Emblok is a privately held, clinical-stage medical device company that is currently enrolling a pivotal, multicenter, randomized controlled trial in the US for its Emblok Embolic Protection System in TAVR. The device aims to provide whole-body embolic protection, capturing debris from major arteries to reduce the risks of stroke, cognitive impairment, and acute kidney injury during transcatheter aortic valve replacement. The device is not yet commercially available and is for investigational use only.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Emblok.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emblok.

Explore the full profile